Spike-antibody waning after second dose of BNT162b2 or ChAdOx1

…, E Fragaszy, S Beale, WLE Fong, P Patel, J Kovar… - The Lancet, 2021 - thelancet.com
Vaccines based on the spike glycoprotein of SARS-CoV-2 are being rolled out globally to
control transmission and limit morbidity and mortality due to COVID-19. Current evidence …

[HTML][HTML] Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study

…, N Goonetilleke, G Harvey, J Kovar… - The Lancet …, 2014 - thelancet.com
Background Assessment of the effect of influenza on populations, including risk of infection,
illness if infected, illness severity, and consultation rates, is essential to inform future control …

[HTML][HTML] Prevalence and characteristics of persistent symptoms in children during the COVID-19 pandemic: evidence from a household cohort study in England and …

…, AMD Navaratnam, M Shrotri, J Kovar… - The Pediatric …, 2022 - journals.lww.com
This work was supported by the Medical Research Council [grant numbers MC_PC19070
and MR/V028375/1, and MR/N013867/1 to Miss Miller] and the Wellcome Trust [grant number …

[HTML][HTML] Spike-antibody responses to COVID-19 vaccination by demographic and clinical factors in a prospective community cohort study

…, AMD Navaratnam, C Geismar, S Beale, J Kovar… - Nature …, 2022 - nature.com
Vaccination constitutes the best long-term solution against Coronavirus Disease-2019;
however, vaccine-derived immunity may not protect all groups equally, and the durability of …

[HTML][HTML] Effects of school closures, 2008 winter influenza season, Hong Kong

…, EHY Lau, CLH Lam, CKY Cheng, J Kovar… - Emerging infectious …, 2008 - ncbi.nlm.nih.gov
In winter 2008, kindergartens and primary schools in Hong Kong were closed for 2 weeks
after media coverage indicated that 3 children had died, apparently from influenza. We …

Risk factors, symptom reporting, healthcare-seeking behaviour and adherence to public health guidance: protocol for Virus Watch, a prospective community cohort …

A Hayward, E Fragaszy, J Kovar, V Nguyen, S Beale… - BMJ open, 2021 - bmjopen.bmj.com
Introduction The coronavirus (COVID-19) pandemic has caused significant global mortality
and impacted lives around the world. Virus Watch aims to provide evidence on which public …

[HTML][HTML] Nucleocapsid and spike antibody responses following virologically confirmed SARS-CoV-2 infection: an observational analysis in the Virus Watch community …

…, E Fragaszy, C Geismar, S Hoskins, J Kovar… - International Journal of …, 2022 - Elsevier
Objectives Seroprevalence studies can provide a measure of SARS-CoV-2 cumulative
incidence, but a better understanding of spike and nucleocapsid (anti-N) antibody dynamics …

Waning of SARS-CoV-2 antibodies targeting the Spike protein in individuals post second dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and risk of …

…, S Beale, I Braithwaite, T Byrne, J Kovar… - MedRxiv, 2021 - medrxiv.org
Background SARS-CoV-2 vaccines stimulate production of antibodies targeting the spike
protein (anti-S). The level of antibodies following vaccination and trajectories of waning may …

[HTML][HTML] SARS-CoV-2 antibodies and breakthrough infections in the Virus Watch cohort

…, S Beale, I Braithwaite, T Byrne, J Kovar… - Nature …, 2022 - nature.com
A range of studies globally demonstrate that the effectiveness of SARS-CoV-2 vaccines wane
over time, but the total effect of anti-S antibody levels on risk of SARS-CoV-2 infection and …

Occupation, work-related contact and SARS-CoV-2 anti-nucleocapsid serological status: findings from the Virus Watch prospective cohort study

…, WLE Fong, E Fragaszy, C Geismar, J Kovar… - Occupational and …, 2022 - oem.bmj.com
Objectives Risk of SARS-CoV-2 infection varies across occupations; however, investigation
into factors underlying differential risk is limited. We aimed to estimate the total effect of …